Anti-PD1 responses in BRAF mutated advanced melanoma patients with prior BRAF inhibitor (BRAFi) or combined BRAF and MEK inhibitor (Combi) therapy
Journal article published in 2015 by
S. Ramanujam,
S. Lo,
B. Kong,
E. Liniker,
M. Carlino 
,
A. Guminski,
A. Menzies,
G. Long
,
A. Guminski,
A. Menzies,
G. Long
